Can phenytoin prevent Alzheimer's disease?

Medical Hypotheses

Volumn 67, Issue 4, 2006, Pages 725-728

  Dhikav, Vikas ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYTOIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CLINICAL TRIAL; COMORBIDITY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; HIPPOCAMPUS; HUMAN; MORBIDITY; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ANTICONVULSANTS; HIPPOCAMPUS; HUMANS; MODELS, BIOLOGICAL; PHENYTOIN;

EID: 33746261334     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.04.038     Document Type: Article

References (17)

1. Farber N.B., Jiang X.P., Heinkel C., and Nemmers B. Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity. Mol Psychiatry 7 7 (2002) 726-733
2. Romanelli M.F., Morris J.C., Ashkin K., and Coben L.A. Advanced Alzheimer's disease is a risk factor for late-onset seizures. Arch Neurol 47 8 (1990) 847-850
3. Velez-Pardo C., Arellano J.I., Cardona-Gomez P., Jimenez Del Rio M., Lopera F., and De Felipe J. CA1 hippocampal neuronal loss in familial Alzheimer's disease presenilin-1 E280A mutation is related to epilepsy. Epilepsia 45 7 (2004) 751-756
4. Hesdorffer D.C., Hauser W.A., Annegers J.F., Kokmen E., and Rocca W.A. Dementia and adult-onset unprovoked seizures. Neurology 46 3 (1996) 727-730
5. Mendez M.F., Catanzaro P., Doss R.C., ARguello R., and Frey II W.H. Seizures in Alzheimer's disease: clinicopathologic study. J. Geriatr Psychiatry Neurol 7 4 (1994) 230-233
6. Menendez M. Down syndrome, Alzheimer's disease and seizures. Brain Dev 27 4 (2005) 246-252
7. Hauser W.A., Morris M.L., Heston L.L., and Anderson V.E. Seizures and myoclonus in patients with Alzheimer's disease. Neurology 36 9 (1986) 1226-1230
8. Rekling J.C. Neuro-protective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation. Neurosci Lett 335 3 (2003) 167-170
9. Mendez M., and Lim G. Seizures in elderly patients with dementia: epidemiology and management. Drugs Aging 20 11 (2003) 791-803
10. Bremner J.D., Mletzko T., Welter S., Quinn S., Williams C., Brummer M., Siddiq S., Reed L., Heim C.M., and Nemeroff C.B. Effects of phenytoin on memory, cognition and brain structure in post-traumatic stress disorder: a pilot study. J Psychopharmacol 19 2 (2005) 159-165
11. McEwen B.S., Conrad C.D., Kuroda Y., Frankfurt M., Magarinos A.M., and McKittrick C. Prevention of stress-induced morphological and cognitive consequences. Eur Neuropsychopharmacol 7 Suppl 3 (1997) S323-S328
12. Watanabe Y., Gould E., Cameron H.A., Daniels D.C., and McEwen B.S. Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus 2 4 (1992) 431-435
13. Brunson K.L., Kramar E., Lin B., Chen Y., Colgin L.L., Yanagihara T.K., Lynch G., and Baram T.Z. Mechanisms of late-onset cognitive decline after early-life stress. J Neurosci 25 41 (2005) 9328-9338
14. Liu R.S., Lemieux L., Bell G.S., Sisodiya S.M., Bartlett P.A., Shorvon S.D., Sander J.W., and Duncan J.S. Cerebral damage in epilepsy: a population-based longitudinal quantitative MRI study. Epilepsia 46 9 (2005) 1482-1494
15. Hashimoto M., Kazui H., Matsumoto K., Nakano Y., Yasuda M., and Mori E. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?. Am J Psychiatry 162 4 (2005) 676-682
16. Czapinski P., Blaszczyk B., and Czuczwar S.J. Mechanisms of action of antiepileptic drugs. Curr Top Med Chem 5 1 (2005) 3-14
17. Naskar R., Quinto K., Romann I., Schuettauf F., and Zurakowski D. Phenytoin blocks retinal ganglion cell death after partial optic nerve crush. Exp Eye Res 74 6 (2002) 747-752